Assessment of the clinical and MRi results of the FREEDOMS and TRANSFORMS phase III. clinical trials
Jakab, G.áb.
Ideggyogyaszati Szemle 65(5-6): 207-208
2012
ISSN/ISBN: 0019-1442 PMID: 22724290 Document Number: 658225
Document emailed within 1 workday
Related Documents
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69Xie, Y.; Wang, Y.; Tian, F.; Wang, Y. 2011: Basic requirements on post-marketing clinical re-evaluation of chinese medicine and phase IV clinical trials Zhongguo Zhong Yao Za Zhi 36(20): 2764-2767
Teehan, M. 1994: Guidelines for phase IV clinical trials. Joint Committee on Phase IV Clinical Trial Guidelines Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 39(10): 629-633
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Jaoko, W.G.; Ogutu, H.; Wakasiaka, S.; Malogo, R.; Ndambuki, R.; Nyange, J.; Omosa-Manyonyi, G.; Fast, P.; Schmidt, C.; Verlinde, C.; Smith, C.; Bhatt, K.M.; Ndinya-Achola, J.; Anzala, O. 2009: Pregnancy rates among female participants in phase i and phase IIA AIDS vaccine clinical trials in Kenya East African Medical Journal 86(9): 430-434
Jaillon, P.; Dupuis, B. 1989: Prerequisites for phase i and phase Ii clinical trials of drugs Archives des Maladies du Coeur et des Vaisseaux 82(10): 1773-1776
1998: Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations Journal of Clinical Psychiatry 59 Suppl. 12: 23-27
Keppler, B.K.; Heim, M.E.; Flechtner, H.; Wingen, F.; Pool, B.L. 1989: Assessment of the preclinical activity of budotitane in three different transplantable tumor systems, its lack of mutagenicity, and first results of clinical phase i studies Arzneimittel-Forschung 39(6): 706-709
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Hunter, C.P.; Frelick, R.W.; Feldman, A.R.; Bavier, A.R.; Dunlap, W.H.; Ford, L.; Henson, D.; Macfarlane, D.; Smart, C.R.; Yancik, R. 1987: Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log Cancer Treatment Reports 71(6): 559-565
Kvien, T.K.; Mikkelsen, K.; Nordvåg, B.ør.-Y. 2003: Results from controlled clinical trials: how relevant for clinical practice? Journal of Rheumatology 30(6): 1135-1137
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Saw, S.M.; Lim, S.G. 2000: Clinical drug trials: practical problems of phase III Annals of the Academy of Medicine Singapore 29(5): 598-605
Durry, G.; Dion, S. 1986: The ethical approach to phase I clinical trials in oncology Drugs under Experimental and Clinical Research 12(1-2): 21-22
Plat, F. 1992: Methodology of phase Ii clinical trials of hypocholesteremic drugs: which criteria? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 117-120
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443